We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTD icon
126
Mettler-Toledo International
MTD
$28.1B
$22.7M 0.16%
20,441
+2,717
+15% +$3.33M
CNC icon
127
Centene
CNC
$31.6B
$22.5M 0.16%
327,159
-18,647
-5% -$1.24M
HST icon
128
Host Hotels & Resorts
HST
$17.4B
$22.5M 0.16%
1,401,509
+820,587
+141% +$13.7M
TENB icon
129
Tenable Holdings
TENB
$3.46B
$22.5M 0.16%
501,554
-8,254
-2% -$371K
KLAC icon
130
KLA
KLAC
$249B
$22.4M 0.16%
487,680
+293,940
+152% +$14.1M
C icon
131
Citigroup
C
$222B
$22.3M 0.16%
540,981
-54,134
-9% -$2.38M
EBAY icon
132
eBay
EBAY
$52.1B
$22M 0.16%
499,600
+103,615
+26% +$4.62M
JBL icon
133
Jabil
JBL
$31.7B
$22M 0.16%
173,190
+80,821
+87% +$8.84M
ILMN icon
134
Illumina
ILMN
$29.2B
$21.6M 0.15%
161,517
-22,632
-12% -$3.72M
PYPL icon
135
PayPal
PYPL
$51.4B
$21.6M 0.15%
368,750
-128,546
-26% -$8.37M
ELV icon
136
Elevance Health
ELV
$83.7B
$21.3M 0.15%
49,020
-13,019
-21% -$5.91M
EG icon
137
Everest Group
EG
$15.8B
$21.2M 0.15%
57,124
+31,451
+123% +$11.4M
FISV
138
Fiserv Inc
FISV
$28.9B
$21.2M 0.15%
187,843
+1,171
+0.6% +$144K
QCOM icon
139
Qualcomm
QCOM
$172B
$21.1M 0.15%
189,928
-214,307
-53% -$24.9M
SRE icon
140
Sempra
SRE
$59.2B
$21M 0.15%
308,288
+229,006
+289% +$16.5M
BRO icon
141
Brown & Brown
BRO
$25B
$20.9M 0.15%
298,635
-91
-0% -$6.49K
IBM icon
142
IBM
IBM
$214B
$20.1M 0.14%
142,991
+1,469
+1% +$209K
HCA icon
143
HCA Healthcare
HCA
$92.8B
$20M 0.14%
81,171
+29,709
+58% +$8.13M
FICO icon
144
Fair Isaac
FICO
$31B
$19.8M 0.14%
22,803
-3,165
-12% -$2.72M
BZ icon
145
Kanzhun
BZ
$7.07B
$19.6M 0.14%
1,392,130
-347,400
-20% -$5.45M
SYF icon
146
Synchrony
SYF
$25.1B
$19.6M 0.14%
640,910
+8,079
+1% +$269K
XENE icon
147
Xenon Pharmaceuticals
XENE
$6.28B
$19.5M 0.14%
569,884
-136,000
-19% -$5.09M
TD icon
148
Toronto Dominion Bank
TD
$199B
$19.5M 0.14%
322,796
+62,293
+24% +$3.88M
DAY
149
DELISTED
Dayforce
DAY
$19.4M 0.14%
286,247
+136,084
+91% +$9.57M
SLAB icon
150
Silicon Laboratories
SLAB
$7.17B
$19.1M 0.14%
165,090
-44,556
-21% -$6.15M

Similar funds

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.